IBKR vs CME

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

IBKR

45.2
AI Score
VS
CME Wins

CME

48.0
AI Score

Investment Advisor Scores

IBKR

45score
Recommendation
HOLD

CME

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric IBKR CME Winner
Forward P/E 31.6456 21.692 CME
PEG Ratio 1.6578 4.6575 IBKR
Revenue Growth 22.3% 0.8% IBKR
Earnings Growth 36.9% 2.5% IBKR
Tradestie Score 45.2/100 48.0/100 CME
Profit Margin 16.5% 63.4% CME
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

IBKR 1M: -5.6% · 3M: +10.7% CME 1M: +15.9% · 3M: -7.0%

Current Technical Phase

IBKR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 44.1 · Price: $87.99

CME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 67

RSI (14): 67.0 · Price: $267.79

Fundamentals Snapshot

Metric IBKR CME
Market Cap
Forward P/E 27.6 20.7
Trailing P/E 34.3 22.7
Revenue (TTM)
Revenue Growth 0.2% 0.0%
Gross Margin 0.9% 1.0%
Operating Margin 0.8% 0.7%
EPS 2.64 11.79
Dividend Yield 0.00% 0.02%

Frequently Asked Questions

Based on our detailed analysis, CME is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.